Antisense IL-10 abrogates the inhibitory effects of IL-10 production by transfected tumor cells

被引:0
|
作者
Parker, G [1 ]
Fernandes, H [1 ]
Chong, SY [1 ]
Czarneski, J [1 ]
Ra, H [1 ]
Lin, YC [1 ]
Raveche, E [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol, Newark, NJ 07103 USA
关键词
tumor immunity; cytokines; IL-10; gene therapy; in vivo animal models;
D O I
10.1080/mccm.6.3.113.119
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Interleukin-10 (IL-10) is a pleiotropic cytokine that has a variety of downregulatory effects on immunologic and inflammatory processes. Ectopic tumor expression of IL-10 inhibited tumor growth, and local administration of antisense IL-10 significantly reversed the effects of IL-10 transfection in P815 mastocytoma. Tissue inhibitors of metalloproteinase (TIMPs) have been associated with decreased tumorigenesis and reduced metastasis, and TIMPs were increased in the region surrounding P815/IL-10 tumors and reduced in antisense IL-10-treated mice. in addition, the antisense IL-10 group had the largest tumor volume and poorest survival when compared with the P815/IL-10 control or sense groups. In summary, our data suggest that, in a mouse model, antisense IL-10 has substantive effects in reducing IL-10 translation and inhibiting IL-10-mediated TIMP upregulation, and, by doing so, allows IL-10-transfected mastocytoma to grow unchecked. Thus, ectopic tumor expression of IL-10 inhibits tumor growth, and antisense IL-10 administration in vivo reverses this protective effect.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 50 条
  • [1] IL-10 or not IL-10: that is the question
    Dragana Jankovic
    Giorgio Trinchieri
    Nature Immunology, 2007, 8 : 1281 - 1283
  • [2] IL-10 or not IL-10: that is the question
    Jankovic, Dragana
    Trinchieri, Giorgio
    NATURE IMMUNOLOGY, 2007, 8 (12) : 1281 - 1283
  • [3] IL-10 in Humans: Lessons from the Gut, IL-10/IL-10 Receptor Deficiencies, and IL-10 Polymorphisms
    Engelhardt, Karin R.
    Grimbacher, Bodo
    INTERLEUKIN-10 IN HEALTH AND DISEASE, 2014, 380 : 1 - 18
  • [4] Inhibition of interieukin-10 (IL-10) production from MOPC 315 tumor cells by IL-10 antisense oligodeoxynucleotides enhances cell-mediated immune responses
    Kim, BG
    Joo, HG
    Chung, IS
    Chung, HY
    Woo, HJ
    Yun, YS
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (08) : 433 - 440
  • [5] Relative IL-10 deficiency and effects of IL-10 therapy in psoriasis
    Asadullah, K
    Stephanek, K
    Leupold, M
    Jasulaitis, D
    Audring, H
    Volk, HD
    Döcke, WD
    Sterry, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 501 - 501
  • [6] Inhibition of interleukin-10 (IL-10) production from MOPC 315 tumor cells by IL-10 antisense oligodeoxynucleotides enhances cell-mediated immune responses
    Byung-Gyu Kim
    Hong-Gu Joo
    In-Sung Chung
    Hee Yong Chung
    Hee-Jong Woo
    Yeon-Sook Yun
    Cancer Immunology, Immunotherapy, 2000, 49 : 433 - 440
  • [7] IL-10 and IL-10 receptor defects in humans
    Glocker, Erik-Oliver
    Kotlarz, Daniel
    Klein, Christoph
    Shah, Neil
    Grimbacher, Bodo
    YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY II, 2011, 1246 : 102 - 107
  • [8] The regulation of IL-10 production by immune cells
    Margarida Saraiva
    Anne O'Garra
    Nature Reviews Immunology, 2010, 10 : 170 - 181
  • [9] The regulation of IL-10 production by immune cells
    Saraiva, Margarida
    O'Garra, Anne
    NATURE REVIEWS IMMUNOLOGY, 2010, 10 (03) : 170 - 181
  • [10] Association between interleukin-10 (IL-10) polymorphisms and IL-10 production of peripheral blood mononuclear cells
    Liu Shyh-Hwa
    Tseng Wei-Ting
    Lu Ming-Yu
    Chang Hsiu-Luan
    Chaung Hso-Chi
    MOLECULAR IMMUNOLOGY, 2012, 51 (01) : 39 - 40